AbCellera Biologics Inc. is a biotechnology firm that specializes in antibody drug discovery and development. The company utilizes a proprietary technology platform to discover antibodies from natural immune responses and has research collaborations with various pharmaceutical companies.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

COM:ABCELLERA

AbCellera Biologics Inc.

Last Close

2.72

22/11 21:00

Market Cap

815.21M

Beta: -

Volume Today

1.80M

Avg: -

Analysis Not Available